Post-doctoral fellowship available to study immune cell trafficking and
Our laboratory has been studying immune cell migration and signal
transduction in the immune system using a variety of methods including
imaging, biophysics, and biochemistry. Projects in the lab involve designing
and implementing biosensors that would allow us to monitor immune cell
migration, turn-over, and signaling in real-time in animals. We are interested
in how the presence of immune cell populations in certain tissues at given
times determines the outcome of immune reactions in the response to
infection and in autoimmunity and cancer.
Who You Are
Candidate should have a PhD or MD/PhD in Immunology, technical
experience with methodologies in immunology, cell biology, molecular
biology, and, ability to think innovatively and rigorously, and a strong
publication record as evidenced by at least one first-author paper published or
accepted in a top tier journal. Qualified candidates must also demonstrate
outstanding communication skills, have a strong passion and commitment to
science and work well within a group. Experience with animal work is
desirable but not essential.
Who We Are
A member of the Roche Group, Genentech has been at the forefront of the biotechnology industry
for more than 40 years, using human genetic information to develop novel medicines for serious and
life-threatening diseases. Genentech has multiple therapies on the market for cancer & other serious
illnesses. Please take this opportunity to learn about Genentech where we believe that our employees
are our most important asset & are dedicated to remaining a great place to work.
The next step is yours. To apply today, click on the "Apply online" button.
Genentech is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status. For more information about equal employment opportunity, visit our Genentech Careers page.